BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11149036)

  • 1. Preoperative systemic 5-fluorouracil does not increase the risk of liver resection.
    Parc Y; Dugué L; Farges O; Hiramatsu K; Sauvanet A; Belghiti J
    Hepatogastroenterology; 2000; 47(36):1703-5. PubMed ID: 11149036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.
    Aloia T; Sebagh M; Plasse M; Karam V; Lévi F; Giacchetti S; Azoulay D; Bismuth H; Castaing D; Adam R
    J Clin Oncol; 2006 Nov; 24(31):4983-90. PubMed ID: 17075116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated liver resection for recurrent metastases from colorectal cancer.
    Taschieri AM; Elli M; Vignati GA; Montecamozzo G; Danelli PG; Kurihara H; Poliziani D
    Hepatogastroenterology; 2003; 50(50):472-4. PubMed ID: 12749250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal triad clamping (TC) or hepatic vascular exclusion (VE) for major liver resection after prolonged neoadjuvant chemotherapy? A case-matched study in 60 patients.
    Benoist S; Salabert AS; Penna C; Karoui M; Julié C; Rougier P; Nordlinger B
    Surgery; 2006 Sep; 140(3):396-403. PubMed ID: 16934601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.
    Nakano H; Oussoultzoglou E; Rosso E; Casnedi S; Chenard-Neu MP; Dufour P; Bachellier P; Jaeck D
    Ann Surg; 2008 Jan; 247(1):118-24. PubMed ID: 18156931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?
    Maire F; Hammel P; Kianmanesh R; Hentic O; Couvelard A; Rebours V; Zappa M; Raymond E; Sauvanet A; Louvet C; Lévy P; Belghiti J; Ruszniewski P
    Surgery; 2009 Jan; 145(1):69-75. PubMed ID: 19081477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of preoperative hepatic arterial infusion chemotherapy in patients undergoing liver resection for colorectal liver metastases.
    Pulitanò C; Arru M; Catena M; Guzzetti E; Vitali G; Ronzoni M; Venturini M; Villa E; Ferla G; Aldrighetti L
    Ann Surg Oncol; 2008 Jun; 15(6):1661-9. PubMed ID: 18373123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
    Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshit K; Nakamori S; Monden M
    Hepatogastroenterology; 2007; 54(73):172-9. PubMed ID: 17419255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of isolated human hepatocyte function following liver resection for colorectal liver metastases: the effects of prior exposure to chemotherapy.
    Hewes JC; Riddy D; Morris RW; Woodrooffe AJ; Davidson BR; Fuller B
    J Hepatol; 2006 Aug; 45(2):263-70. PubMed ID: 16635536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.
    Martin RC; Edwards MJ; McMasters KM
    Am J Surg; 2004 Dec; 188(6):714-21. PubMed ID: 15619489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.
    Yan TD; Padang R; Morris DL
    J Am Coll Surg; 2006 Jan; 202(1):100-11. PubMed ID: 16377503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment efficacy of surgical management for liver metastasis from colorectal cancer--a report of 198 cases].
    Zhang ZG; Song C; Wang H
    Ai Zheng; 2006 May; 25(5):596-8. PubMed ID: 16687081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases.
    Tanaka K; Shimada H; Ueda M; Matsuo K; Endo I; Sekido H; Togo S
    Surgery; 2006 May; 139(5):599-607. PubMed ID: 16701091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases.
    Kandutsch S; Klinger M; Hacker S; Wrba F; Gruenberger B; Gruenberger T
    Eur J Surg Oncol; 2008 Nov; 34(11):1231-6. PubMed ID: 18272318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
    Witte RS; Cnaan A; Mansour EG; Barylak E; Harris JE; Schutt AJ
    Cancer; 2001 Mar; 91(5):1020-8. PubMed ID: 11251955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
    Lorenz M; Staib-Sebler E; Gog C; Proschek D; Jauch KW; Ridwelski K; Hohenberger W; Gassel HJ; Lehmann U; Vestweber KH; Padberg W; Zamzow K; Müller HH
    Zentralbl Chir; 2003 Feb; 128(2):87-94. PubMed ID: 12632273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial infusion chemotherapy through a port-catheter system as preoperative initial therapy in patients with advanced liver dysfunction due to synchronous and unresectable liver metastases from colorectal cancer.
    Iguchi T; Arai Y; Inaba Y; Yamaura H; Sato Y; Miyazaki M; Shimamoto H
    Cardiovasc Intervent Radiol; 2008; 31(1):86-90. PubMed ID: 17926088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interim analysis of a prospective, randomized multi-center study by the "Liver Metastases" Study Group: adjuvant intra-arterial chemotherapy after curative liver resection of colorectal metastases].
    Lorenz M; Müller HH; Schramm H; Gassel HJ; Hauss J; Ridwelski K; Schäfer H
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):523-8. PubMed ID: 14518310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated hepatic intra-arterial chemotherapy based on results of anticancer drug sensitivity test in patients with synchronous hepatic metastases from colorectal cancer.
    Matsuoka H; Nagaya M; Tsukikawa S; Yanagi Y; Isogai A; Kubota S
    Surgery; 2006 Sep; 140(3):387-95. PubMed ID: 16934600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.